Top Journalists
>
Katie Kalvaitis

Katie Kalvaitis

Editorial Director / Medical Editor & Reporter at Cardiology - Healio

Contact this person
Email address
k*****@*******.comGet email address
Influence score
41
Phone
(XXX) XXX-XXXXGet mobile number
Location
United States
Languages
  • English
Covering topics
  • Health & Medicine

View more media outlets and journalists by signing up to AI PR

View latest data and reach out all from one place
Sign up to AI PR Toolkit

Recent Articles

healio.com

Misinformation about cholesterol ‘widespread’ on TikTok

BOSTON — Much of the health-related content about cholesterol on social media, in particular TikTok, is inaccurate, according to research presented at the American Society for Preventive Cardiology Congress on CVD Prevention.Due to increasing use of social media to search for health-related content, researchers conducted a study that looked at the top videos on TikTok using the search terms
healio.com

Emerging therapies for lowering Lp(a): ‘Peering into the future’

BOSTON — There are a number of emerging therapies in development for lowering lipoprotein(a), and later-stage trials are underway.Interest continues to grow in lipoprotein(a), commonly known as Lp(a), both as a risk factor for CVD, as well as therapies to lower levels of Lp(a).
healio.com

Development of heart failure may accelerate cognitive decline in ol...

BOSTON — Older adults who developed incident HF showed acute declines in cognition, memory and executive function, followed by a steep decline in cognitive function in subsequent years, according to results of a prospective cohort study.Although it is known that about 40% to 60% of patients who develop HF may have cognitive impairment, how HF impacts the trajectory of cognitive function and
healio.com

Remote atrial fibrillation screening with wearable ECG patch confer...

A remote screening strategy for asymptomatic atrial fibrillation involving use of an ECG patch for continuous ambulatory monitoring conferred a modest increase in AF diagnoses after 2.5 years among older adults at risk for stroke.The fully remote, randomized AMALFI trial evaluated long-term efficacy of AF screening via use of a 14-day patch-based continuous ambulatory ECG monitor (Zio XT,
healio.com

Antihypertensive therapy step-down strategy not beneficial for frai...

Progressive discontinuation of antihypertensive medications did not lower risk for mortality compared with usual care among older nursing home residents with frailty, according to results from the RETREAT-FRAIL trial.“RETREAT-FRAIL is the first randomized controlled trial to evaluate the long-term effects of an antihypertensive treatment step-down [strategy] on mortality, morbidity [and]
healio.com

Evolocumab lowers risk for first major cardiovascular events

NEW ORLEANS — In patients with atherosclerosis and/or diabetes without a prior heart attack or stroke, evolocumab cut the risk for first major adverse CV events by 25% compared with placebo, according to results of the VESALIUS-CV trial.Lowering LDL cholesterol with PCSK9 inhibitors, including evolocumab (Repatha, Amgen), lowers risk for CV events in patients with a prior major
healio.com

Daily caffeinated coffee tied to less atrial fibrillation recurrence

NEW ORLEANS — Adults with atrial fibrillation who drank a cup a day of caffeinated coffee were less likely to have recurrent AF or atrial flutter compared with those who avoided all caffeinated products, researchers reported.Coffee is frequently considered to be pro-arrhythmic and patients often cite coffee as a trigger for their AF episodes, Christopher X. Wong, MBBS, MPH, PhD, formerly
healio.com

Burden of pregnancy-related cardiovascular complications increasing...

The burden of maternal cardiometabolic comorbidities and incident pregnancy-related CV complications has increased substantially over the past 20 years in the United States, according to recent research.“We have seen a steady, decades-long rise in both baseline cardiovascular risk at conception and the downstream complication rates in a relatively young population. Women are entering
healio.com

Prior stroke doubles risk for recurrent event during and after preg...

Qureshi AI, et al. Abstract DP006. Presented at: International Stroke Conference; Feb. 4-6, 2026; New Orleans. A prior history of ischemic stroke may signal higher risk for another stroke during pregnancy and in the early postpartum period, researchers reported at the International Stroke Conference.
healio.com

Catheter-directed thrombolysis superior to anticoagulation for acut...

NEW ORLEANS — In the HI-PEITHO trial, ultrasound-facilitated catheter-directed thrombolysis plus anticoagulation conferred better 30-day outcomes compared with anticoagulation alone in patients with acute intermediate-risk pulmonary embolism.At the American College of Cardiology Scientific Session, researchers reported results from 544 adults (mean age, 58 years; 43% women; 15.8%
healio.com

Mavacamten shows benefit for adolescents with obstructive hypertrop...

NEW ORLEANS — New data support the use of mavacamten as a treatment option for adolescents with symptomatic obstructive hypertrophic cardiomyopathy, researchers reported at the American College of Cardiology Scientific Session.The SCOUT-HCM trial is the first to evaluate mavacamten (Camzyos, Bristol Myers Squibb) in adolescents. Mavacamten, a cardiac myosin inhibitor, is currently FDA